Novogen (KZIA) Institutional Ownership $7.70 +0.41 (+5.55%) Closing price 03:58 PM EasternExtended Trading$7.70 0.00 (0.00%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Novogen (NASDAQ:KZIA)CurrentInstitutional OwnershipPercentage30.89%Number ofInstitutional Buyers(last 12 months)2TotalInstitutional Inflows(last 12 months)$30.38MNumber ofInstitutional Sellers(last 12 months)0 Get KZIA Insider Trade Alerts Want to know when executives and insiders are buying or selling Novogen stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data KZIA Institutional Buying and Selling by Quarter Novogen Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/13/2025 Barclays PLC120,000$212K0.0%N/A2.381% 11/7/2024 MAI Capital Management1,363,894$586K0.0%N/A51.663% 2/14/2024 Platinum Investment Management Ltd.1,821,887$801K0.0%N/A11.150% 2/13/2024 Armistice Capital LLC2,475,555$1.09M0.0%N/A15.150% 3/6/2023 OLD Mission Capital LLC42,765$26K0.0%-47.2%0.308% 11/14/2022 OLD Mission Capital LLC80,923$89K0.0%N/A0.583% 7/29/2022 SG Americas Securities LLC13,988$59K0.0%-41.5%0.106% 4/29/2022 SG Americas Securities LLC23,899$184K0.0%-29.9%0.181% 2/7/2022 SG Americas Securities LLC34,106$288K0.0%-14.3%0.258% 2/4/2022 Envestnet Asset Management Inc.26,412$223K0.0%N/A0.200% 11/1/2021 SG Americas Securities LLC39,776$450K0.0%-10.4%0.301% 10/21/2021 Total Clarity Wealth Management Inc.4,755$54K0.0%N/A0.036% 8/13/2021 Renaissance Technologies LLC65,823$649K0.0%+188.2%0.508% 8/12/2021 SG Americas Securities LLC44,398$438K0.0%+12.1%0.343% 5/18/2021 Morgan Stanley230,801$2.86M0.0%+28.5%1.781% (Data available from 1/1/2016 forward) KZIA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of KZIA shares? During the previous two years, the following institutional investors and hedge funds held shares of Novogen shares: Armistice Capital LLC ($1.09M), Platinum Investment Management Ltd. ($801K), and MAI Capital Management ($586K), Barclays PLC ($212K).Learn more on Novogen's institutional investors. What percentage of Novogen's stock is owned by institutional investors? 30.89% of Novogen's stock is owned by institutional investors. Learn more on KZIA's institutional investor holdings. Which institutional investors have been buying Novogen's stock? The following institutional investors have purchased Novogen's stock in the last 24 months: Armistice Capital LLC ($2.48M), Platinum Investment Management Ltd. ($1.82M), MAI Capital Management ($1.36M), and Barclays PLC ($120K). How much institutional buying is happening at Novogen? Institutional investors have bought a total of 1,483,894 shares in the last 24 months. This purchase volume represents approximately $30.38M in transactions. Related Companies SCYX Major Shareholders RANI Major Shareholders KPTI Major Shareholders ITRM Major Shareholders AKTX Major Shareholders ALXO Major Shareholders BTAI Major Shareholders CLSD Major Shareholders EQ Major Shareholders CLNN Major Shareholders This page (NASDAQ:KZIA) was last updated on 8/22/2025 by MarketBeat.com Staff From Our PartnersOne tiny company just cracked Google’s $19B problemGoogle, Microsoft, IBM… every major AI player will be forced to secure massive amounts of this material just t...True Market Insiders | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredBREAKING: The House just passed 3 pro-crypto bills!The “top secret” DeFi play Our #1 Coin Report reveals which protocol is building this institutional bridge...Crypto 101 Media | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredTax Drain Deadline: Protect Your Wealth Before September 15thOn September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredElon Musk’s New TechnologyElon Musk is building something in Memphis that could eclipse even Tesla and SpaceX. At the heart of it is a n...Paradigm Press | SponsoredCould This Be the End of Retirement Worries?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Novogen Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Novogen With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.